Share：
Share this content in WeChat
X
[Chinese][PDF]133073
• Review •
Research progresses in imaging of charcot neuropathic osteoarthropathy in diabetic foot
XIE Liqiu  LI Yongmei 

Cite this article as: Xie LQ, Li YM. Research progresses in imaging of charcot neuropathic osteoarthropathy in diabetic foot. Chin J Magn Reson Imaging, 2019, 10(3): 228-231. DOI:10.12015/issn.1674-8034.2019.03.014.


[Abstract] Charcot neuropathic osteoarthropathy (CN) is a chronic, progressive disease of bones, joints, and soft tissues. The disease usually occurrs in the foot and ankle as a result of diabetic peripheral neuropathy. Due to gross instability, recurrent ulcerations, it is a deforming and destructive disease process. Early diagnosis and differentiation CN from osteomyelitis are critical to guide treatment. It can exist concomitantly with osteomyelitis, typically in the setting of an advanced midfoot ulcer. Conventional examination methods often yield inconclusive or confusing data. Various advanced MR imaging protocols not only may improve the diagnostic accuracy of MR imaging and the ability of differenting CN from osteomyelitis, but also may help in making treatment decision and lead to improving patient outcomes. We aim to make a review about the recent imaging research progress in CN.
[Keywords] charcot neuropathic osteoarthropathy；diagnostic imaging；diabetes mellitus；peripheral nerves

XIE Liqiu Department Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

LI Yongmei* Department Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

*Correspondence to: Li YM, E-mail: lymzhang70@aliyun.com

Conflicts of interest   None.

Received  2018-09-17
Accepted  2018-11-18
DOI: 10.12015/issn.1674-8034.2019.03.014
Cite this article as: Xie LQ, Li YM. Research progresses in imaging of charcot neuropathic osteoarthropathy in diabetic foot. Chin J Magn Reson Imaging, 2019, 10(3): 228-231. DOI:10.12015/issn.1674-8034.2019.03.014.

[1]
Kucera T, Shaikh HH, Sponer P. Charcot neuropathic arthropathy of the foot: a literature review and single-center experience. J Diabetes Res, 2016, 2016(296): 1-10.
[2]
Larson SA, Burns PR. The pathogenesis of Charcot neuroarthropathy: current concepts. Diabet Foot Ankle, 2012, 3(1): 1-10.
[3]
Rogers LC, Frykberg RG, Armstrong DG et al. The Charcot foot in diabetes. Diabetes Care, 2011, 34(9): 2123-2129.
[4]
Trieb K. The Charcot foot: pathophysiology, diagnosis and classification. Bone Joint J, 2016, 98-B(9): 1155-1159.
[5]
Kaynak G, Birsel O, Güven MF, et al. An overview of the Charcot foot pathophysiology. Diabet Foot Ankle, 2013, 4(4): 211-217.
[6]
Ndip A, Williams A, Jude EB, et al. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes, 2011, 60(8): 2187-2196.
[7]
Rosenbaum AJ, DiPreta JA. Classifications in brief: eichenholtz classification of Charcot arthropathy. Clin Orthop Relat Res, 2015, 473(3): 1168-1171.
[8]
Womack J. Charcot arthropathy versus osteomyelitis: evaluation and management. Orthop Clin North Am, 2017, 48(2): 241-247.
[9]
Hastings MK, Johnson JE, Strube MJ, et al. Progression of foot deformity in Charcot neuropathic osteoarthropathy. J Bone Joint Surg Am, 2013, 95(13): 1206-1213.
[10]
Rogers LC, Bevilacqua NJ. Imaging of the Charcot foot. Clin Podiatr Med Surg, 2008, 25(2): 263-274.
[11]
Mautone M, Naidoo P. Charcot foot: imaging insights from the high risk diabetic foot MDT. Eur Congr Radiol, 2015, 22(3): 17-22.
[12]
Gutekunst DJ, Smith KE, Commean PK, et al. Impact of Charcot neuroarthropathy on metatarsal bone mineral density and geometric strength indices. Bone, 2013, 52(1): 407-413.
[13]
Mautone M, Naidoo P. What the radiologist needs to know about Charcot foot. J Med Imaging Radiat Oncol, 2015, 59(4):395-402.
[14]
Ergen FB, Sanverdi SE, Oznur A. Charcot foot in diabetes and an update on imaging. Diabet Foot Ankle, 2013, 4(11): 1-8.
[15]
Chantelau EA, Antoniou S, Zweck B, et al. Follow up of MRI bone marrow edema in the treated diabetic Charcot foot: a review of patient charts. Diabet Foot Ankle, 2018, 9(1): 1466-1471.
[16]
Ledermann HP, Morrison WB. Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: MR imaging. Semin Musculoskelet Radiol, 2005, 9(3): 272-283.
[17]
Zampa V, Bargellini I, Rizzo L, et al. Role of dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus. Skeletal Radiol, 2011, 40(8): 991-999.
[18]
Basu S, Chryssikos T, Houseni M, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun, 2007, 28(6): 465-472.
[19]
Abdel Razek AA, Samir S. Diagnostic performance of diffusion-weighted MR imaging in differentiation of diabetic osteoarthropathy and osteomyelitis in diabetic foot. Eur J Radiol, 2017, 89: 221-225.
[20]
Martín NT, Luna AA, Beltrán LS, et al. Advanced MR imaging techniques for differentiation of neuropathic arthropathy and osteomyelitis in the diabetic foot. Radiographics, 2017, 37(4): 1161-1180.
[21]
Liao D, Xie L, Han Y, et al. Dynamic contrast-enhanced magnetic resonance imaging for differentiating osteomyelitis from acute neuropathic arthropathy in the complicated diabetic foot. Skeletal Radiol, 2018, 47(2): 1-11.
[22]
Maas M, Slim EJ, Heoksma AF, et al. MR imaging of neuropathic feet in leprosy patients with suspected osteomyelitis. Int J Lepr Other Mycobact Dis, 2002, 70(2): 97-103.
[23]
Fontaine JL, Lavery L, Jude E. Current concepts of Charcot foot in diabetic patients. Foot, 2016, 26: 7-14.
[24]
Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabet Care, 2011, 34(9): 2123-2129.
[25]
Tomas MB, Patel M, Marwin SE, et al. The diabetic foot. Br J Radiol, 2014, 73(868): 443-450.
[26]
Pickwell KM, van Kroonenburgh MJ, Weijers RE, et al. F-18 FDG PET/CT scanning in Charcot disease: a brief report. Clin Nucl Med, 2011, 36(1): 8-10.
[27]
Wang GL, Zhao K, Liu ZF, et al. A meta-analysis of fluorodeoxyglucose-positronemission tomography versus scintigraphy in the evaluation of suspected osteomyelitis. Nucl Med Commun, 2011, 32(12): 1134-1142.
[28]
Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br, 2004, 86(3): 378-383.
[29]
Płaza M, Nowakowskapłaza A, Walentowskajanowicz M, et al. Charcot arthropathy in ultrasound examination: a case report. J Ultrason, 2016, 16(65): 210-215.

PREV Present research situation of the MRI manifastations of spinal infection and its imitations
NEXT Advances in imaging research of diabetes-related sarcopenia
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn